Composite Histiocytic Sarcoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma of the Ocular Adnexa.
Journal
Ophthalmic plastic and reconstructive surgery
ISSN: 1537-2677
Titre abrégé: Ophthalmic Plast Reconstr Surg
Pays: United States
ID NLM: 8508431
Informations de publication
Date de publication:
11 Apr 2024
11 Apr 2024
Historique:
medline:
16
4
2024
pubmed:
16
4
2024
entrez:
16
4
2024
Statut:
aheadofprint
Résumé
Histiocytic sarcoma (HS) is a rare and aggressive hematologic neoplasm characterized by the proliferation of malignant histiocytes. It infrequently presents with periorbital involvement. Here we present the first documented case of ocular adnexal histiocytic sarcoma composite with chronic lymphocytic leukemia/small lymphocytic lymphoma and provide compelling evidence for the transdifferentiation of chronic lymphocytic leukemia/small lymphocytic lymphoma to histiocytic sarcoma in an 80-year-old woman. Comprehending the clinicopathological characteristics of histiocytic sarcoma and various other histiocytic proliferations and neoplasms affecting orbital and ocular structures is imperative for ophthalmic surgeons and pathologists.
Identifiants
pubmed: 38624159
doi: 10.1097/IOP.0000000000002670
pii: 00002341-990000000-00377
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc.
Déclaration de conflit d'intérêts
The authors have no financial or conflicts of interest to disclose.
Références
Kommalapati A, Tella SH, Durkin M, et al. Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes. Blood 2018;131:265–268.
Takahashi E, Nakamura S. Histiocytic sarcoma: an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop 2013;53:1–8.
Emile JF, Abla O, Fraitag S, et al.; Histiocyte Society. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 2016;127:2672–2681.
Krishna Y, Araujo I, Warrier S, et al. Diffuse histiocytic sarcoma involving the choroid. JAMA Ophthalmol 2016;134:1198–1200.
Mittal N, Aakalu V, Mehendele S, et al. Primary orbital histiocytic sarcoma in a child successfully treated with multiagent chemotherapy. J Pediatr Hematol Oncol 2016;38:653–657.
Li Y, Sun W, Huang Y. Orbital apex syndrome in a patient with histiocytic sarcoma. JAMA Neurol 2019;76:364–365.
Liu DJ, Rullo J, Kratky V, et al. Histiocytic sarcoma of the eyelid. Saudi J Ophthalmol 2019;33:300–303.
Zhang X, Wang LP, Ziober A, et al. Ionized calcium binding adaptor molecule 1 (IBA1): a novel, highly sensitive, and specific marker for histiocytic, dendritic, and monocytic neoplasms. Am J Clin Pathol 2021;156:86–99.
Vos JA, Abbondanzo SL, Barekman CL, et al. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol 2005;18:693–704.
Herwig MC, Wojno T, Zhang Q, et al. Langerhans cell histiocytosis of the orbit. Surv Ophthalmol 2013;58:330–340.
Goyal G, Heaney ML, Collin M, et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood 2020;135:1929–1945.
Salari B, Dehner LP. Juvenile and adult xanthogranuloma: a 30-year single-center experience and review of the disorder and its relationship to other histiocytoses. Ann Diagn Pathol 2022;58:151940.
Ríos y Valles-Valles D, Herrera-Cifuentes SL, Rodríguez-Reyes AA, et al. Rosai-dorfman disease involving the eye and ocular adnexa. Clinicopathologic series of 17 patients. Eur J Ophthalmol 2023;33:1216–1223.
Wang L, Suo L, Kou F, et al. Ocular phenotypes in patients with hemophagocytic lymphohistiocytosis: a retrospective analysis in a single center over 7 years. Am J Ophthalmol 2023;253:119–131.
Ravindran A, Dasari S, Ruan GJ, et al.; Mayo Clinic-The University of Alabama at Birmingham Histiocytosis Working Group. Malignant histiocytosis comprises a phenotypic spectrum that parallels the lineage differentiation of monocytes, macrophages, dendritic cells, and Langerhans cells. Mod Pathol 2023;36:100268.
Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 2022;36:1720–1748.
Xiao W, Amador C, Cook JR, et al. B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: report from the 2021 SH/EAHP Workshop. Am J Clin Pathol 2023;159:522–537.
García-Cosío M, Santón A, Martín P, et al. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin’s lymphoma. Mod Pathol 2004;17:1531–1538.
Egan C, Nicolae A, Lack J, et al. Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups. Haematologica 2020;105:951–960.
Shanmugam V, Griffin GK, Jacobsen ED, et al. Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma. Mod Pathol 2019;32:830–843.